Our sponsors

At Bayer, we understand the importance of self-care in enhancing quality of life both now and in the future. However, not everyone has access to these vital health solutions, like digestive health, allergy relief, nutritional supplements, and pain management treatments. We’re committed to closing this gap by helping billions of people live healthier lives through our trusted self-care solutions.

Bayer’s Consumer Health Division offers a portfolio of trusted health self-care solutions, ranging from globally recognized brands to locally relevant products, and including leading herbal formulations that have been researched and tested over decades, as well as probiotics, according to Bayer’s mission « health for all ».

The Schwabe Group comprises several different affiliated companies in the pharmaceutical and health industry. All of the companies within the Group focus on plants as the basis for developing pharmaceuticals and health products.

The original company of the Schwabe Group, which is now Dr. Willmar Schwabe GmbH & Co. KG, is one of the oldest pharmaceutical manufacturers in Europe and has a company history dating back 160 years.

Collaborative Drug Discovery (CDD) offers an easy-to-use software platform designed for biotech companies and academic research teams. Its main product, CDD Vault, helps scientists organize and manage both biological and chemical data through a straightforward interface. With built-in AI for predictive modeling and molecule design (alongside tools for Registration, Inventory, and an Electronic Lab Notebook) CDD Vault turns experimental data into practical insights that help speed up drug discovery.

The mission of Celabor is to place the bioeconomy at the heart of industrial activities in order to create value, support innovation and enhance the societal impact of businesses. Inspired by nature – a symbol of efficiency, balance and renewal – we transform its resources into reliable, responsible and results-oriented solutions. We act on the conviction that a high-performing economy can also be one that protects and improves the world in which we live.

Our biomass extraction platform is an innovation hub dedicated to the circular bioeconomy. Designed to transform organic waste into high-value-added resources, it utilises advanced fractionation processes such as extraction using green solvents or supercritical CO2. This infrastructure enables the precise isolation of bioactive molecules, essential oils and fibres for the cosmetics, pharmaceutical, nutraceutical and energy sectors. By maximising the potential of each raw material, our industrial unit minimises its environmental footprint and actively supports the transition to a sustainable, low-carbon economy.

Frontiers in Pharmacology is the world’s most cited pharmacology and pharmacy journal, advancing high-quality, peer-reviewed research to improve human health and therapeutic innovation. Our unique approach to research integrity brings together expert editorial boards, rigorous peer review, and AI-supported tools to ensure the highest quality standards.

With 19 specialty sections, the journal covers the full spectrum of pharmacology, led by its prominent Ethnopharmacology section, dedicated to publishing research focused on the study of traditional medicines, including those used in modern healthcare settings and its pharmacological effects.

At PhytoLab, we understand that sound decisions in product development and quality assurance depend on accurate, reliable analytical data. In industries defined by complexity and regulatory demands, having a trusted analytical partner makes all the difference.

PhytoLab offers a comprehensive range of analytical services for the characterization and quality control of raw materials, extracts, and finished products. From identity testing and quantitative analysis to stability studies and method development, our expert team supports clients across the pharmaceutical, nutraceutical, food, and cosmetics industries at every stage — from incoming goods inspection to final product release. Built on decades of analytical and regulatory expertise, PhytoLab delivers the scientific precision and transparency that modern quality assurance requires.

Cfm Oskar Tropitzsch GmbH assists the chemical, pharmaceutical, and biotechnological industries in sourcing and producing chemical specialties. The core of its work is to supply the products customers are looking for – with the right documentation, the correct quantity from milligrams to metric tons, and proper quality. This is not limited to one-off transactions but includes supporting projects from the R&D stage up to commercial production.

To achieve these challenging goals, Cfm Oskar Tropitzsch GmbH relies on its excellent know-how and worldwide network of qualified suppliers. “Finding the best solution!” is not just a phrase – it is the company’s mission.

Lilichro Ltd. is a deep-tech company focused on Centrifugal Partition Chromatography (CPC), an advanced liquid–liquid separation technology enabling high-efficiency purification without solid stationary phases. We design and manufacture pharmaceutical-grade systems used across pharma, biotech, and natural extract companies to purify complex mixtures with precision and scalability.

From early R&D to full-scale production, we help teams reduce process risk, increase yield, and transition to a more sustainable, high-performance alternative to traditional chromatography. It’s time to scale up!

MDPI is a leader in the transition to open science by making more research free and accessible to everyone. Over 4.5 million researchers have entrusted us with publishing their scientific discoveries.

Our aim is to ensure that high-quality research is verified and made available to the research community as quickly as possible. MDPI stands at the forefront of the open access movement, having launched its first online journal Molecules in 1996. Today, MDPI is a leader in open access publishing with more than 500+ journals across all research disciplines. Every article is published under a Creative Commons Attribution License.

• 669.1 K submissions received in 2025
• 500+ open access journals
• 18 days from submission to first decision in 2025 (median across all journals)
• 43 days from submission to publication in 2025 (median across all journals)
• 97% of 2025 articles covered in Web of Science
• 90+ journals covered in SCIE (Web of Science)
• 93% of submitting authors rate their overall experience with the peer review process as Excellent/Good
• 261.6 K articles published in 2025

At Zeller, we are dedicated to advancing modern phytotherapy through clinically proven herbal solutions. As the leading Swiss company in the development and manufacture of phytopharmaceuticals, we combine more than 160 years of expertise with a consistent commitment to scientific research, quality and innovation. One of the few companies to control the entire value chain “from seed to finished product”, Zeller stands for reliability, efficacy and safety. Our portfolio includes OTC products, prescription medicines and evidence based food supplements supporting patients across a broad range of therapeutic areas.

Patients increasingly seek therapies that deliver proven clinical efficacy without compromising tolerability. Guided by its commitment to Decoding Nature. Empowering Health., Bionorica® addresses this need with evidence-based herbal medicines developed according to the highest pharmaceutical research and quality standards.

Headquartered in Neumarkt, Germany, Bionorica® is a global leader in phytotherapy. Its products are trusted by physicians, pharmacists, and patients in more than 55 countries worldwide.

With its unique Phytoneering approach, Bionorica® bridges ancient knowledge about the power of nature with state-of-the-art pharmaceutical technology to develop effective phytomedicines for respiratory and urinary tract diseases, women’s health, and digestive disorders – consistently living its promise of Decoding Nature. Empowering Health.

FLAVEX Naturextrakte GmbH specializes in the production of botanical extracts using supercritical carbon dioxide as a natural solvent. For over 40 years, the privately owned company has served the cosmetics, perfumery, food, and nutraceutical industries with a wide range of high-quality plant extracts.

The clean and eco-friendly CO2 extraction technology preserves the full spectrum of sensitive top notes and bioactive substances of herbs and spices, for example antioxidants, natural flavors, essential oils and special fatty oils.

All products are developed, manufactured, and certified in Rehlingen-Siersburg, Germany, near the borders of France and the Benelux region.

PharmaGnose delivers cutting-edge R&D services and high-quality natural products for the pharmaceutical, cosmetic and agro-food industries. Guided by innovation, sustainability and the unique potential of Greek biodiversity, PharmaGnose combines advanced research, green technologies and market-oriented product development to transform natural substances into valuable active ingredients.

With longstanding experience and deep expertise in aromatic and medicinal plants, particularly from the Mediterranean region, PharmaGnose combines scientific knowledge with a modern, innovation-driven approach to support the development of high-quality natural products for global markets, with a strong commitment to sustainability and excellence.